Activity of Wedelia calendulacea Less. in post-menopausal osteoporosis

被引:29
|
作者
Annie, S [1 ]
Prabhu, RG
Malini, S
机构
[1] Coll Pharmaceut Sci, Dept Pharmacognosy, Manipal, India
[2] Kasturba Med Coll & Hosp, Dept Pharmacol, Manipal, India
关键词
Wedelia calendulace; isoflavonoids; rat model; post-menopausal osteoporosis;
D O I
10.1016/j.phymed.2004.01.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Wedelia calendulacea Less., a perennial herb containing isoflavanoids, is used in liver disorders, uterine hemorrhage and menorrhagia. Osteoporosis in women occurs mainly due to estrogen deficiency following menopause. Studies indicate that isoflavones are estrogenic enough to promote bone formation. Our study was aimed to investigate the antiosteoporotic effect of the ethanol extract of W. calendulacea in the ovariectomized rat model of osteoporosis, at two different dose levels of 500 and 750 mg/kg/body wt. day. The findings, assessed on the basis of biomechanical and biochemical parameters, showed that the ethanol extract of the plant had a definite protective effect. This was further supported by the histopathological studies. Phytochemical investigation revealed the presence of isoflavones and wedelolactone, which are known to act as phytoestrogens and may be responsible for the antiosteoporotic activity. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
  • [41] Neuropharmacological studies on Wedelia calendulacea Less stem extract
    Prakash, T.
    Rao, N. Rama
    Swamy, A. H. M. Viswanatha
    PHYTOMEDICINE, 2008, 15 (11) : 959 - 970
  • [42] A SURVEY OF TREATMENT ATTITUDES TO POST-MENOPAUSAL OSTEOPOROSIS
    UNDERWOOD, PN
    BOYLE, IT
    SCOTTISH MEDICAL JOURNAL, 1983, 28 (03) : 259 - 264
  • [43] TREATMENT OF SPINAL OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN
    NORDIN, BEC
    HORSMAN, A
    CRILLY, RG
    MARSHALL, DH
    SIMPSON, M
    BRITISH MEDICAL JOURNAL, 1980, 280 (6212): : 451 - 454
  • [44] PROLACTIN AND ESTROGENS IN OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN
    LENZA, HR
    MEDICINA CLINICA, 1982, 78 (09): : 372 - 375
  • [45] DEFICIT IN CALCITONIN RESERVE IN POST-MENOPAUSAL OSTEOPOROSIS
    CHESNUT, CH
    TAGGART, HM
    BAYLINK, DJ
    IVEY, J
    SISOM, K
    ROOS, BA
    CLINICAL RESEARCH, 1981, 29 (02): : A403 - A403
  • [46] POST-MENOPAUSAL OSTEOPOROSIS - PREVENTION VERSUS CURE
    AVIOLI, LV
    FEDERATION PROCEEDINGS, 1981, 40 (09) : 2418 - 2422
  • [47] OUR EXPERIENCE IN THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS
    LENZA, HR
    PEREZ, DE
    MEDICINA CLINICA, 1982, 78 (08): : 322 - 325
  • [48] CURRENT RESEARCH IN THERAPY OF POST-MENOPAUSAL OSTEOPOROSIS
    LAROCHE, C
    DETILLEUX, M
    SERENI, D
    SEMAINE DES HOPITAUX, 1979, 55 (7-8): : 325 - 329
  • [49] Treatment of post-menopausal osteoporosis: beyond bisphosphonates
    S. Ishtiaq
    I. Fogelman
    G. Hampson
    Journal of Endocrinological Investigation, 2015, 38 : 13 - 29
  • [50] GERMAN GUIDELINES FOR THE MANAGEMENT OF POST-MENOPAUSAL OSTEOPOROSIS
    Thomasius, F.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S65 - S65